Nexsen logo
NXN

Nexsen

Pharmaceuticals, Biotechnology & Life Sciences

Short position

short percentage0.02%
reported shorts21.8K
shares on issue92.766M

Nexsen (ASX:NXN) has 0.02% of its shares on issue reported as short positions as of 6 July 2026, or about 21,838 shares. NXN is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

Nexsen (NXN) Short Interest

Nexsen (ASX:NXN) had 0.02% of shares reported as short positions as of 6 July 2026, representing 21,838 shares. Nexsen operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.

Strategy fit

How each stock picker strategy reads NXN today

Prices to 9 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

NXN fundamentals

In the year to 30 Jun 2026, Nexsen (ASX:NXN) recorded revenue of A$1.1M and a net loss after tax of A$6.6M. A year earlier it recorded revenue of A$931.6K and a net loss after tax of A$5.0M. Year-on-year growth: revenue +16.9% (FY). Net margin −601.8% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit) and Yahoo Finance, as at 29 Sep 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →

About

Company information is being updated. Check back soon.

More Pharmaceuticals, Biotechnology & Life Sciences Stocks

Other shorted stocks in this sector

Be the first to discuss NXN

Start a research thread or post the first pulse update